Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Doramectin--a potent novel endectocide

A C Goudie1, N A Evans, K A Gration

  • 1Pfizer Central Research, Sandwich, UK.

Veterinary Parasitology
|July 1, 1993
PubMed
Summary

Doramectin, a novel avermectin, shows potent antiparasitic activity in animal models and cattle. This compound demonstrates favorable efficacy and persistent action against key gastrointestinal and lung parasites in cattle.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating dissolved phosphorus losses from legacy sources in pastures: The limits of soil tests and small-scale rainfall simulators.

Journal of environmental quality·2021
Same author

Ecology of Increasing Diseases: Population Growth and Environmental Degradation.

Human ecology: an interdisciplinary journal·2020
Same author

Retrospective evaluation of moderate-to-severe pulmonary hypertension in dogs naturally infected with Angiostrongylus vasorum.

The Journal of small animal practice·2014
Same author

Multiple aneurysms in the female breast: a case report.

The British journal of radiology·2007
Same author

Current computer use by diabetes educators.

The Diabetes educator·2002
Same author

Workload and stress in consultant medical microbiologists and virologists: a questionnaire survey.

Journal of clinical pathology·2002

Area of Science:

  • Veterinary Parasitology
  • Drug Discovery
  • Pharmacokinetics

Background:

  • Novel avermectins were synthesized via mutational biosynthesis.
  • Doramectin emerged as the lead compound from this series.
  • Existing avermectins like ivermectin are crucial antiparasitic agents.

Purpose of the Study:

  • To evaluate the in vivo antiparasitic efficacy of doramectin.
  • To compare doramectin's performance against dihydroavermectin B1a (DHAVM).
  • To assess doramectin's pharmacokinetics and persistent activity in cattle.

Main Methods:

  • In vivo testing in rat Trichostrongylus colubriformis and rabbit Psoroptes cuniculi models.
  • Subcutaneous administration of doramectin in a micelle formulation to cattle.

Related Experiment Videos

  • Intravenous administration for pharmacokinetic analysis in cattle.
  • Experimental infection models for Ostertagia ostertagi, Cooperia oncophora, and Dictyocaulus viviparus.

    • Main Results:

    • Doramectin demonstrated superior or comparable efficacy to DHAVM in initial models.
    • Highly effective subcutaneous administration (200 µg/kg) against O. ostertagi, C. oncophora, and D. viviparus in cattle.
    • Plasma half-life of doramectin in cattle was approximately 89 hours.
    • Persistent activity observed for 8 and 12 days against C. oncophora and O. ostertagi, respectively, at 400 µg/kg.

    Conclusions:

    • Doramectin is a highly effective novel avermectin with significant antiparasitic properties.
    • Its pharmacokinetic profile supports sustained activity, making it a promising candidate for parasitic disease control in cattle.
    • Doramectin offers a valuable new therapeutic option for managing common cattle parasites.